Auteur M. HERDENER

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Cannabis consumers' view of regulated access to recreational cannabis: A multisite survey in Switzerland

M. MULLER ; E. P. MESZAROS ; M. WALTER ; L. BALTES-FLUCKIGER ; M. HERDENER ; R. AUER ; G. THORENS ; S. ROTHEN ; C. NORDT ; D. ZULLINO | 2023
Dans European Addiction Research (Vol.29, n°3, July 2023) Article : Périodique

INTRODUCTION: There is considerable effort in legalizing recreational use of cannabis globally. The successful implementation of a program of regulated access to recreational cannabis (PRAC) depends on the consumers' engagement. The aim of this [...]

Plus d'info

Ajouter à la sélection

Lien externe

Cannabis use in Switzerland 2015-2045: A population survey based model

M. VOGEL ; C. NORDT ; R. BITAR ; L. BOESCH ; M. WALTER ; E. SEIFRITZ ; K. M. DURSTELER ; M. HERDENER | 2019
Dans International Journal of Drug Policy (Vol.69, July 2019) Article : Périodique

Background: Alternative cannabis regulation models are discussed and implemented worldwide. A baseline scenario under the assumption of no policy or market changes may prove useful to forecast cannabis use and treatment demand and evaluate chang[...]

Plus d'info

Ajouter à la sélection

Concomitant heroin and cocaine use among opioid-dependent patients during methadone, buprenorphine or morphine opioid agonist therapy

S. GASTBERGER ; M. R. BAUMGARTNER ; M. SOYKA ; B. B. QUEDNOW ; L. M. HULKA ; M. HERDENER ; E. SEIFRITZ ; J. MUTSCHLER | 2019
Dans European Addiction Research (Vol.25, n°4, June 2019) Article : Périodique

BACKGROUND: Among all the treatment methods developed so far, opioid agonist treatment (OAT) is the most effective therapy for opioid dependence. While methadone (MTD) is the most commonly used, fewer data are available on alternative opioid ago[...]

Plus d'info

Ajouter à la sélection

Lien externe

Rethinking retention in treatment of opioid dependence - The eye of the beholder

M. VOGEL ; K. M. DURSTELER ; M. WALTER ; M. HERDENER ; C. NORDT | 2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique

Opioid dependence often is a chronic relapsing disorder. The evidence for medication-assisted treatment (MAT) being the treatment of first choice is unequivocal. Yet, health systems, professionals and patients often fail to offer or, respectivel[...]

Plus d'info

Ajouter à la sélection

Telecommunications network measurements of online gambling behavior in Switzerland: A feasibility study

R. BITAR ; C. NORDT ; M. GROSSHANS ; M. HERDENER ; E. SEIFRITZ ; J. MUTSCHLER | 2017
Dans European Addiction Research (Vol.23, n°2, May 2017) Article : Périodique

BACKGROUND: Methodological shortcomings of gambling studies relying on self-report or on data sets derived from gambling operators tend to result in biased conclusions. The aim of this study was to analyze online gambling behavior using a novel [...]

Plus d'info

Ajouter à la sélection

The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol

M. BUSCHNER ; N. HECKEL ; P. DURLER ; E. J. E. ENGELI ; S. SCHNEIDER ; E. M. HAVELKA ; C. NORDT ; M. HERDENER | 2024
Dans International Journal of Drug Policy (Vol.133, November 2024) Article : Périodique

Background and Aims: Recreational use of cannabis is illegal in most countries. Despite this, it is the third most commonly used psychoactive substance worldwide. As a result of this discrepancy, a growing number of countries have begun to reass[...]

Plus d'info

Ajouter à la sélection

Lien externe